A

argenx

Develops antibody-based therapies for autoimmune diseases

Neurology Territory Business Manager - Overlay

Field SalesUpdated on Nov 12
Full-time

About the Job

Requirements

  • A B.S. or B.A. degree is required.
  • At least 5 years of specialty, rare disease, or biologics sales experience is required; neurology experience is strongly preferred.
  • Demonstrated ability to sell collaboratively and succeed within a highly coordinated team environment.
  • High level of clinical, product, and business acumen.
  • Ability to translate data and customer insights into action.
  • Understanding of market access dynamics, with emphasis on specialty pharmacy and buy-and-bill accounts.
  • Proven track record of consistent high sales performance.
  • Ability to plan, organize, and execute sales strategy.
  • Ability to collaborate with internal stakeholders and field-based partners.
  • Ability to adapt to an ever-changing environment.
  • Experience in product launches.
  • Candidates must live in the territory.

Responsibilities

  • Travel regularly throughout the assigned geography, which may require overnight stays, and occasionally travel beyond it.
  • Plan the territory and develop local market strategy aligned with launch priorities.
  • Collaborate with local Territory Business Managers, regional colleagues, and cross-functional team members to align customer strategy and coordinate engagement.
  • Communicate and engage with assigned healthcare professionals and affiliated staff.
  • Consistently meet and exceed sales and launch objectives.
  • Effectively utilize market tools and resources.
  • Submit account plans and activity, including customer relationship management records, in a timely manner.
  • Adhere to company compliance policies, guidelines, and approved sales messages.

Desired Qualifications

  • Local market knowledge is preferred.
  • Neurology sales experience is strongly preferred.

About the Company

argenx

Develops antibody-based therapies for autoimmune diseases

Argenx develops and markets antibody-based therapies for severe autoimmune diseases, turning immunology research into medicines. Its lead drug, efgartigimod (VYVGART), and the subcutaneous VYVGART Hytrulo treat conditions like generalized myasthenia gravis and CIDP by modulating the immune system through FcRn pathways. The company differentiates itself with antibody engineering and a co-creation model with academic and industry partners, plus a pipeline targeting FcRn-, complement-, and other autoimmune pathways and a global development footprint. Its goal is to provide effective antibody medicines for autoimmune diseases and broaden global patient access.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Amsterdam, Netherlands
Founded
2008

Recently Posted Jobs

Explore more opportunities at argenx

See more jobs